Key facts
- This page summarizes John Jed Kennedy Power's Form 4 filing for CONMED Corp (CNMD).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2022, 16:08.
John Jed Kennedy Power - 03 Mar 2022 Form 4 Insider Report for CONMED Corp (CNMD)
- Reporting relationship
- Group Executive Vice President
- Issuer ticker
- CNMD
- Reported as of
- 03 Mar 2022
- Net transaction value
- -$585,368
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2022, 16:08:23 UTC
- Prior SEC filing
- 03 Mar 2022
- Next SEC filing
- 10 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Jed Kennedy Power filed Form 4 for CONMED Corp (CNMD) on 07 Mar 2022.
Change
- Previous filing in this sequence was filed on 03 Mar 2022.
- Current net transaction value: -$585,368.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $305,316
- Shares
- +5,092
- Change %
- +52%
- Price
- $59.96
- Shares after
- 14,947
- Date
- 03 Mar 2022
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $734,532
- Shares
- -5,092
- Change %
- -34%
- Price
- $144.25
- Shares after
- 9,855
- Date
- 03 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $140,980
- Shares
- +1,790
- Change %
- +18%
- Price
- $78.76
- Shares after
- 11,645
- Date
- 03 Mar 2022
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $258,328
- Shares
- -1,790
- Change %
- -15%
- Price
- $144.32
- Shares after
- 9,855
- Date
- 03 Mar 2022
- Ownership
- Direct
- Footnotes
- F2
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $81,278
- Shares
- +832
- Change %
- +8.4%
- Price
- $97.69
- Shares after
- 10,687
- Date
- 03 Mar 2022
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $120,083
- Shares
- -832
- Change %
- -7.8%
- Price
- $144.33
- Shares after
- 9,855
- Date
- 03 Mar 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -5,092
- Change %
- -49%
- Price
- $0.000000
- Shares after
- 5,400
- Date
- 03 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,092
- Exercise price
- $59.96
- Footnotes
- F4
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -1,790
- Change %
- -32%
- Price
- $0.000000
- Shares after
- 3,800
- Date
- 03 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,790
- Exercise price
- $78.76
- Footnotes
- F5
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -832
- Change %
- -11%
- Price
- $0.000000
- Shares after
- 6,768
- Date
- 03 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 832
- Exercise price
- $97.69
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F4
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Footnote F5
The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period